De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.
Standard
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. / Rivière, Jean-Baptiste; Mirzaa, Ghayda M; O'Roak, Brian J; Beddaoui, Margaret; Alcantara, Diana; Conway, Robert L; St-Onge, Judith; Schwartzentruber, Jeremy A; Gripp, Karen W; Nikkel, Sarah M; Worthylake, Thea; Sullivan, Christopher T; Ward, Thomas R; Butler, Hailly E; Kramer, Nancy A; Albrecht, Beate; Armour, Christine M; Armstrong, Linlea; Caluseriu, Oana; Cytrynbaum, Cheryl; Drolet, Beth A; Innes, A Micheil; Lauzon, Julie L; Lin, Angela E; Mancini, Grazia M S; Meschino, Wendy S; Reggin, James D; Saggar, Anand K; Lerman-Sagie, Tally; Uyanik, Gökhan; Weksberg, Rosanna; Zirn, Birgit; Beaulieu, Chandree L; Consortium, Finding Of Rare Disease Genes Canada; Majewski, Jacek; Bulman, Dennis E; O'Driscoll, Mark; Shendure, Jay; Graham, John M; Boycott, Kym M; Dobyns, William B.
In: NAT GENET, Vol. 44, No. 8, 8, 2012, p. 934-940.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.
AU - Rivière, Jean-Baptiste
AU - Mirzaa, Ghayda M
AU - O'Roak, Brian J
AU - Beddaoui, Margaret
AU - Alcantara, Diana
AU - Conway, Robert L
AU - St-Onge, Judith
AU - Schwartzentruber, Jeremy A
AU - Gripp, Karen W
AU - Nikkel, Sarah M
AU - Worthylake, Thea
AU - Sullivan, Christopher T
AU - Ward, Thomas R
AU - Butler, Hailly E
AU - Kramer, Nancy A
AU - Albrecht, Beate
AU - Armour, Christine M
AU - Armstrong, Linlea
AU - Caluseriu, Oana
AU - Cytrynbaum, Cheryl
AU - Drolet, Beth A
AU - Innes, A Micheil
AU - Lauzon, Julie L
AU - Lin, Angela E
AU - Mancini, Grazia M S
AU - Meschino, Wendy S
AU - Reggin, James D
AU - Saggar, Anand K
AU - Lerman-Sagie, Tally
AU - Uyanik, Gökhan
AU - Weksberg, Rosanna
AU - Zirn, Birgit
AU - Beaulieu, Chandree L
AU - Consortium, Finding Of Rare Disease Genes Canada
AU - Majewski, Jacek
AU - Bulman, Dennis E
AU - O'Driscoll, Mark
AU - Shendure, Jay
AU - Graham, John M
AU - Boycott, Kym M
AU - Dobyns, William B
PY - 2012
Y1 - 2012
N2 - Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes are sporadic overgrowth disorders associated with markedly enlarged brain size and other recognizable features. We performed exome sequencing in 3 families with MCAP or MPPH, and our initial observations were confirmed in exomes from 7 individuals with MCAP and 174 control individuals, as well as in 40 additional subjects with megalencephaly, using a combination of Sanger sequencing, restriction enzyme assays and targeted deep sequencing. We identified de novo germline or postzygotic mutations in three core components of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. These include 2 mutations in AKT3, 1 recurrent mutation in PIK3R2 in 11 unrelated families with MPPH and 15 mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and 1 with MPPH. Our data highlight the central role of PI3K-AKT signaling in vascular, limb and brain development and emphasize the power of massively parallel sequencing in a challenging context of phenotypic and genetic heterogeneity combined with postzygotic mosaicism.
AB - Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes are sporadic overgrowth disorders associated with markedly enlarged brain size and other recognizable features. We performed exome sequencing in 3 families with MCAP or MPPH, and our initial observations were confirmed in exomes from 7 individuals with MCAP and 174 control individuals, as well as in 40 additional subjects with megalencephaly, using a combination of Sanger sequencing, restriction enzyme assays and targeted deep sequencing. We identified de novo germline or postzygotic mutations in three core components of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. These include 2 mutations in AKT3, 1 recurrent mutation in PIK3R2 in 11 unrelated families with MPPH and 15 mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and 1 with MPPH. Our data highlight the central role of PI3K-AKT signaling in vascular, limb and brain development and emphasize the power of massively parallel sequencing in a challenging context of phenotypic and genetic heterogeneity combined with postzygotic mosaicism.
KW - Humans
KW - Mutation, Missense
KW - Syndrome
KW - Mutation
KW - Germ-Line Mutation
KW - Exome
KW - Hydrocephalus/enzymology/genetics/pathology
KW - Macrocephaly/enzymology/genetics/pathology
KW - Malformations of Cortical Development/enzymology/genetics/pathology
KW - Phosphatidylinositol 3-Kinases/genetics
KW - Proto-Oncogene Proteins c-akt/genetics
KW - Humans
KW - Mutation, Missense
KW - Syndrome
KW - Mutation
KW - Germ-Line Mutation
KW - Exome
KW - Hydrocephalus/enzymology/genetics/pathology
KW - Macrocephaly/enzymology/genetics/pathology
KW - Malformations of Cortical Development/enzymology/genetics/pathology
KW - Phosphatidylinositol 3-Kinases/genetics
KW - Proto-Oncogene Proteins c-akt/genetics
M3 - SCORING: Journal article
VL - 44
SP - 934
EP - 940
JO - NAT GENET
JF - NAT GENET
SN - 1061-4036
IS - 8
M1 - 8
ER -